| Makale Türü |
|
||
| Dergi Adı | Journal of Infection in Developing Countries (Q4) | ||
| Dergi ISSN | 2036-6590 | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 01-2023 |
| Cilt / Sayı / Sayfa | 17 / 1 / 37–42 | DOI | 10.3855/jidc.17409 |
| Makale Linki | http://dx.doi.org/10.3855/jidc.17409 | ||
| UAK Araştırma Alanları |
Anesteziyoloji ve Reanimasyon
|
||
| Özet |
| Introduction: Despite significant advances in the management of patients with COVID-19, there is a need for markers to guide treatment and predict disease severity. In this study, we aimed to evaluate the relationship of the ferritin/albumin (FAR) ratio with disease mortality.Methodology: Acute Physiology and Chronic Health Assessment II scores and laboratory results of patients diagnosed with severe COVID-19 pneumonia were retrospectively analyzed. The patients were divided into two groups: survivors and non-survivors. Data for ferritin, albumin, and ferritin/albumin ratio among COVID-19 patients were analyzed and compared.Results: The mean age was higher in non-survivors (p= 0.778, p< 0.001, respectively). The ferritin/albumin ratio was significantly higher in the non-survival group (p< 0.05). Taking the cut-off value of the ferritin/albumin ratio of 128.71 in the ROC analysis, it predicted the critical clinical status of COVID-19 with 88.4% sensitivity and 88.4% specificity.Conclusions: ferritin/albumin ratio is a practical, inexpensive, and easily accessible test that can be used routinely. In our study, the ferritin/albumin ratio has been identified as a potential parameter in determining the mortality of critically ill COVID-19 patients treated in intensive care. |
| Anahtar Kelimeler |
| Albumin | COVID-19 | ferritin | ferritin/albumin ratio | mortality | predictive |
| Atıf Sayıları | |
| Web of Science | 8 |
| Scopus | 11 |
| Google Scholar | 13 |